Tracked shipping to Austria with premium packaging for just 3,99 € 

Ship to
Austria
0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

Select your country

Americas

Europe

Rest of the world

portada Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)
Type
Physical Book
Publisher
Language
English
Pages
386
Format
Paperback
ISBN13
9789400738300

Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)

Hayat, M. A. (Author) · Springer · Paperback

Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2) - Hayat, M. A.

Cheaper New Book Imported to Austria
Delivery: 15 Jul - 20 Jul Shipping: 13 to 15 business days.
216,22 €
Faster New Book Imported to Austria
Delivery: 15 Jul - 17 Jul Shipping: 13 to 14 business days.
245,80 €
Import costs and 10% VAT included in the price ✅
216,22 €

Synopsis "Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)"

This volume mainly contains information on the diagnosis, therapy, and prognosis of brain tumors. Insights on the understanding of molecular pathways involved in tumor biology are explained, which should lead to the development of effective drugs. Information on pathways (e.g., hedgehog) facilitates targeted therapies in cancer. Tumor models are also presented, which utilize expression data, pathway sensitivity, and genetic abnormalities, representing targets in cancer. For example, rat model of malignant brain tumors using implantation of doxorubicin with drug eluting beads for delivery is explained. The future of pathway-driven therapies for tumors is summarized. The importance of personalizing cancer care is emphasized. The need for supportive measures for survivors of brain cancer is pointed out, so is the quality of life monitoring. The need of rehabilitation therapy for patients with primary and metastatic brain tumors is also emphasized. Role of MicroRNA in distinguishing primary tumors from metastatic primary tumors is discussed. Advantages and limitations of chemotherapy (e.g., temozolomide and doxorubicin) are discussed. The complexity of tumor to tumor transfer is explained; examples discussed are: brain metastases from breast cancer and brain metastases fro non-small cell lung carcinoma. Identification and characterization of biomarkers, including those for metastatic brain tumors, are presented. Genomic analysis for identifying clinically relevant subtypes of glioblastoma is included. A large number of imaging modalities are detailed to study progression and invasion of gliomas

Customers reviews

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews